Receptor-mediated endocytosis of plasminogen activators and activator/inhibitor complexes.
about
Direct binding of occupied urokinase receptor (uPAR) to LDL receptor-related protein is required for endocytosis of uPAR and regulation of cell surface urokinase activityProstate cancer relevant antigens and enzymes for targeted drug deliveryCollagenase-3 binds to a specific receptor and requires the low density lipoprotein receptor-related protein for internalizationRole of membrane organization and membrane domains in endocytic lipid trafficking.Protein misfolding and the serpinopathies.Epitope-mapped monoclonal antibodies as tools for functional and morphological analyses of the human urokinase receptor in tumor tissueDetection of mRNAs for urokinase-type plasminogen activator, its receptor, and type 1 inhibitor in giant cell tumors of bone with in situ hybridization.Identification of the second cluster of ligand-binding repeats in megalin as a site for receptor-ligand interactionsLBD1 of Vitellogenin Receptor Specifically Binds to the Female-Specific Storage Protein SP1 via LBR1 and LBR3.Clustered folate receptors deliver 5-methyltetrahydrofolate to cytoplasm of MA104 cells.Plasmin and plasminogen activator inhibitor type 1 promote cellular motility by regulating the interaction between the urokinase receptor and vitronectin.Urokinase-type plasminogen activator receptor is internalized by different mechanisms in polarized and nonpolarized Madin-Darby canine kidney epithelial cells.A cleavage-resistant urokinase plasminogen activator receptor exhibits dysregulated cell-surface clearance.Plasminogen activator inhibitor type 1 in cancer: therapeutic and prognostic implications.PAI-1 gene expression is regionally induced in wounded epithelial cell monolayers and required for injury repair.Urokinase-type plasminogen activator (uPA) and its receptor (CD87): a new target in tumor invasion and metastasis.Very low density lipoprotein receptor binds and mediates endocytosis of urokinase-type plasminogen activator-type-1 plasminogen activator inhibitor complex.Bound plasminogen is rate-limiting for cell-surface-mediated activation of plasminogen by urokinaseThe chicken oocyte receptor for lipoprotein deposition recognizes alpha 2-macroglobulin.Very low density lipoprotein receptor from mammary gland and mammary epithelial cell lines binds and mediates endocytosis of M(r) 40,000 receptor associated protein.Phosphodiesterase isozymes: molecular targets for novel antiasthma agents.Role and localization of urokinase receptor in the formation of new microvascular structures in fibrin matrices.Effect of surface charge and ligand organization on the specific cell-uptake of uPAR-targeted nanoparticles.Binding areas of urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex for endocytosis receptors of the low-density lipoprotein receptor family, determined by site-directed mutagenesis.Inhibitory activity of the Drosophila melanogaster serpin Necrotic is dependent on lysine residues in the D-helix.The Urokinase/PAI-2 Complex
P2860
Q24633333-5F1BF409-7855-4768-8FA7-5EC0B42C1CE1Q27013843-093EBE93-896D-4B75-B9E6-3BD2E4FD973CQ28145656-66D1C774-5D3A-4DEA-B08E-62D69F72E176Q34156593-029E04CC-C382-4403-AFAE-1011F9D3F890Q34928474-00C47B8A-21F8-419F-BC8C-B093D508CC82Q35764327-29118A19-473B-48EF-A2C1-DD0F46C6E8B4Q35796413-15454EB3-07AB-490E-9C48-D5DA0CF6785EQ36041570-BB160BB4-58DF-4140-A427-9CC42B82E5C7Q36135836-0A9498BD-A8BC-4C85-A2C6-9C88593C812EQ36237309-744749FA-11AD-48AB-A370-FBDB4905F2D7Q37369504-9C45D66F-3E33-4D8F-81B8-33A248A39C3DQ38609665-7430F19F-0060-49A4-9135-A82869A4B516Q40105822-5199CEBC-D6F8-463D-B940-42CB962D15ADQ40475372-F11C08B8-C8A8-4BA8-86E9-1C82BF1BB540Q40907981-D245F7C6-1120-402B-9404-2919C3E46B81Q40942602-9179B3C7-420D-4EAB-B641-4DF06D0144ADQ41301968-3AB95952-F076-419A-A4EA-4C9DD59CB4A3Q41317577-339B8F46-0B36-4275-8C97-E338DF21F0A3Q41358731-0D293674-4459-4163-8FC5-AA21E0D915FCQ41429335-0319CA52-02D8-4156-91A7-A8C21396AB95Q41708863-D6B3C302-8352-4002-9ACD-FAC5C02C2B54Q42113244-CA5C9EB2-1C20-4C3B-8E57-CB532DFE2F30Q44008835-3F42FAEC-91D1-4E30-82B5-626ED8BE11A6Q46584036-4B51D59C-25AA-4D37-BA72-10C787960F89Q52670119-C0A0E596-F00D-4E89-8579-DAAA04E6B46EQ57372452-5AFEA9BC-691D-4394-970B-E44B37C934AB
P2860
Receptor-mediated endocytosis of plasminogen activators and activator/inhibitor complexes.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Receptor-mediated endocytosis ...... activator/inhibitor complexes.
@en
type
label
Receptor-mediated endocytosis ...... activator/inhibitor complexes.
@en
prefLabel
Receptor-mediated endocytosis ...... activator/inhibitor complexes.
@en
P2093
P2860
P1433
P1476
Receptor-mediated endocytosis ...... activator/inhibitor complexes.
@en
P2093
Andreasen PA
Gliemann J
Petersen CM
Sottrup-Jensen L
P2860
P304
P356
10.1016/0014-5793(94)80276-9
P407
P577
1994-02-01T00:00:00Z